Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1993 | 12-1992 | 09-1992 | 06-1992 | 03-1992 | |
| Sales | 1,560,000 | 1,655,400 | 1,476,500 | 1,478,300 | 1,557,100 |
| Cost of Goods | 446,600 | 483,800 | 532,500 | 445,600 | 435,100 |
| Gross Profit | 1,113,400 | 1,171,600 | 944,000 | 1,032,700 | 1,122,000 |
| Operating Expenses | 605,700 | 681,000 | 732,300 | 595,800 | 542,000 |
| Operating Income | 508,300 | 491,400 | 212,200 | 437,500 | 580,100 |
| Other Income | 21,500 | -46,900 | -597,800 | 49,000 | 56,800 |
| Pre-tax Income | 529,800 | 444,500 | -385,600 | 486,500 | 636,900 |
| Income Tax | 156,300 | 129,200 | -117,100 | 148,300 | 194,300 |
| Net Income Continuous | 373,500 | 343,475 | -268,500 | 340,200 | 444,700 |
| Net Income Discontinuous | -10,900 | -1,031,275 | 0 | -1,998,000 | -118,900 |
| Net Income | $362,600 | $311,200 | $-268,500 | $340,200 | $325,800 |
| EPS Basic Total Ops | 0.31 | 0.27 | -0.23 | 0.29 | 0.38 |
| EPS Basic Continuous Ops | 0.32 | 0.29 | -0.23 | 0.29 | 0.38 |
| EPS Basic Discontinuous Ops | -0.01 | -0.88 | N/A | -1.70 | -0.10 |
| EPS Diluted Total Ops | 0.31 | 0.27 | -0.23 | 0.29 | 0.28 |
| EPS Diluted Continuous Ops | 0.32 | 0.29 | -0.23 | 0.29 | 0.38 |
| EPS Diluted Discontinuous Ops | -0.01 | -0.88 | N/A | -1.70 | -0.10 |
| EBITDA(a) | $508,300 | $491,400 | $212,200 | $437,500 | $580,100 |